Johnson Investment Counsel Inc. Has $1.66 Million Holdings in Cigna Group $CI

Johnson Investment Counsel Inc. lessened its holdings in Cigna Group (NYSE:CIFree Report) by 5.3% during the second quarter, Holdings Channel reports. The fund owned 5,009 shares of the health services provider’s stock after selling 282 shares during the period. Johnson Investment Counsel Inc.’s holdings in Cigna Group were worth $1,656,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Flaharty Asset Management LLC bought a new stake in Cigna Group in the 1st quarter valued at $28,000. 1248 Management LLC bought a new stake in Cigna Group in the 1st quarter valued at $29,000. Activest Wealth Management raised its stake in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 72 shares during the period. Retirement Wealth Solutions LLC raised its stake in Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 43 shares during the period. Finally, Saudi Central Bank bought a new stake in Cigna Group in the 1st quarter valued at $36,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE:CI opened at $295.60 on Tuesday. The stock’s 50-day simple moving average is $295.25 and its 200 day simple moving average is $308.92. The firm has a market capitalization of $78.90 billion, a PE ratio of 16.14, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a twelve month low of $256.89 and a twelve month high of $358.88.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s revenue was up 11.0% compared to the same quarter last year. During the same period last year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is presently 32.97%.

Analyst Ratings Changes

Several research analysts have weighed in on CI shares. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Robert W. Baird set a $372.00 price objective on Cigna Group in a research report on Thursday, August 14th. Barclays increased their price objective on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Royal Bank Of Canada reiterated an “outperform” rating and set a $371.00 price objective on shares of Cigna Group in a research report on Thursday, June 26th. Finally, Guggenheim restated a “buy” rating and issued a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $372.69.

Read Our Latest Analysis on Cigna Group

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.70% of the company’s stock.

Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.